About Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency
Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency is a rare disease catalogued by Orphanet (ORPHA:88639). It is associated with the HIBCH gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency trials.
Search ClinicalTrials.gov for "Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency" or filter by Orphanet code ORPHA:88639 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency. Updated daily.